Strengthening research capacities of Comprehensive Cancer Infrastructures
Summary
Missions aim to address some of the greatest challenges facing our society. They are bold and inspirational with clear objectives that are time-bound, realistic, measurable and targeted. Theυ are linked to research and innovation and aim to address social challenges with systemic solutions, leading to social transformations and social impact.
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Call
Detailed Call Description
Building inter alia on the work carried out in several joint actions, the work of organisations in the area of accreditation and certification, the work that will be carried out under the Europe’s Beating Cancer Plan, as well as existing and potential future mappings, a capacity-building programme should be set up for Member States and several Associated Countries in the EU network of Comprehensive Cancer Centres, to be established through the Europe’s Beating Cancer Plan, in order to help them develop or further improve digital, research & innovation-related capacities of future or existing Comprehensive Cancer Infrastructures.
Proposals should address all of the following:
- The capacity-building programme should be organised over the course of three years, with at least one training session taking place in each Member State and those Associated Countries in the EU network of Comprehensive Cancer Centres, to be established through the Europe’s Beating Cancer Plan. In the planning of the capacity-building programme, sufficient time should be allocated to ensure proper follow-up and implementation of the recommendations provided to the participating countries.
- Each training session shall be tailored to the needs of the participating country. These needs shall be identified and discussed with the participating country prior to the session. This concerns in particular the required participants / stakeholder groups, duly reflecting health and research system specificities.
- The capacity-building programme should start in countries with no existing Comprehensive Cancer Infrastructure, followed by those with some existing Comprehensive Cancer Infrastructures but needing substantial improvement, and then support the further development of Comprehensive Cancer Infrastructures in countries with an already established system.
- The training sessions shall consist of balanced theoretical and practical parts, including simulations, case studies, group exercises, mutual learning exercises and on-the-spot visits (when possible) to gather practical experience.
- At the end of each training session, a report shall be produced indicating the areas identified for improvement and suggesting recommendations and a follow-up for the participating country. This should include information on available EU (funding) instruments as well as any other suitable sources of support for the areas identified for improvement.
- After the initial session, the project should provide an on-demand support service to the participating country(ies) to ensure proper follow-up and support for the implementation of the recommendations provided.
- Proposals should consider, as part of this follow-up, to invite the country to participate to a supplementary and more focused session. The possibility of a twinning activity with another country which is more advanced on the areas identified for improvement should be explored as part of this follow-up.
- Proposals should consider including the following areas of development or improvement of future or existing Comprehensive Cancer Infrastructures in their capacity building activities:
- Enhanced involvement in and quality of scientific research, including development and participation to clinical trials and epidemiological studies (e.g. clinical trial design, process of trial approval, ethical aspects, recruitment, staffing and training requirements including digital skills, organisational aspects, regulatory requirements, core facilities, patient participation and empowerment (in the planning and implementation of patient-oriented cancer research);
- Better integration between research and care programmes;
- Improvement of patient care pathways and integrated care;
- Development and use of indicators (e.g. quality, outcomes) and registries;
- Implementation of quality assurance and related standards;
- Support in accreditation and certification;
- Networking capacities (within and across Member States), including through improvement of data exchange capacities (e.g. interoperability and data protection related aspects);
- Gender-related aspects (with respect to representation in research and career pathways and any other relevant aspects).
- At the end of the capacity-building programme, an overall report shall be produced, highlighting transferable best practices and lessons learned from the capacity-building programme and the support provided.
Due consideration should be given to other relevant EU-funded initiatives. This capacity-building programme should be built and conducted in full synergy and complementarity with the actions foreseen under the Europe‘s Beating Cancer Plan, with the Commission acting as a facilitator.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
The Commission estimates that an EU contribution of around EUR 10.00 million would allow these outcomes to be addressed appropriately. Nonetheless, this does not preclude submission and selection of a proposal requesting different amounts.
Programme Category
EU Competitive ProgrammesTotal Budget
€10 000 000Thematic Categories
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Associations
- Central Government
- Educational Institutions
- International Organisations
- Large Enterprises
- Local Authorities
- NGOs
- Non Profit Organisations
- Researchers/Research Centers/Institutions
- Services Providers
- Small and Medium Enterprises (SMEs)
- State-owned Enterprises
Call Opening Date
24/05/2022Call Closing Date
07/09/2022National Contact Point(s)
Research and Innovation Foundation
29a Andrea Michalakopoulou, 1075 Nicosia
P.O.Box 23422, 1683 Nicosia
Phone Number: +357 22205000
Email Address: support@research.org.cy
Website: https://www.research.org.cy/en/
Contact Person:
Myrto Anastassiadou
Contact Phone: +357 22 205 069
Contact Email: manastassiadou@research.org.cy
